Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after ...
Colorado and Florida are among at least nine states that have passed laws allowing for Canadian drug importation. Colorado's ...
The FDA has approved Rapiblyk, a new drug to treat irregular heartbeats in critically ill hospitalized patients with severe ...
The submission for treating paediatric plaque psoriasis is supported by outcomes from the Phase III PROTOSTAR study in ...
Four million people are unable to tolerate one of the most common food allergies in the U.S. The allergy typically lasts a ...
The FDA has rejected Applied Therapeutics’ attempt to win approval on the strength of a failed phase 3 trial, triggering a 75 ...
Despite hotly debated biomarkers and failed or delayed confirmatory trials, the accelerated approval program has a track ...
Gland Pharma receives USFDA approval for Latanoprost Ophthalmic Solution, strengthening its position in the US pharmaceutical ...
Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...
Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...
Collaboration with Janssen aims to fast-track the launch and enhance accessibility to YESINTEK for patients in need.
The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed ...